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Abstract
Vector-borne transmission of Chagas disease has become an urban problem in the city of Arequipa, Peru, yet
the debilitating symptoms that can occur in the chronic stage of the disease are rarely seen in hospitals in the
city. The lack of obvious clinical disease in Arequipa has led to speculation that the local strain of the etiologic
agent, Trypanosoma cruzi, has low chronic pathogenicity. The long asymptomatic period of Chagas disease
leads us to an alternative hypothesis for the absence of clinical cases in Arequipa: transmission in the city may
be so recent that most infected individuals have yet to progress to late stage disease. Here we describe a new
method, epicenter regression, that allows us to infer the spatial and temporal history of disease transmission
from a snapshot of a population's infection status. We show that in a community of Arequipa, transmission of
T. cruzi by the insect vector Triatoma infestans occurred as a series of focal micro-epidemics, the oldest of
which began only around 20 years ago. These micro-epidemics infected nearly 5% of the community before
transmission of the parasite was disrupted through insecticide application in 2004. Most extant human
infections in our study community arose over a brief period of time immediately prior to vector control.
According to our findings, the symptoms of chronic Chagas disease are expected to be absent, even if the
strain is pathogenic in the chronic phase of disease, given the long asymptomatic period of the disease and
short history of intense transmission.
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Introduction
Chagas disease, responsible for more deaths in the Americas
than any other parasitic disease [1], has become an urban problem
in the city of Arequipa, Peru [2,3]. Nevertheless the debilitating
symptoms of chronic Chagas disease, common across southern
South America, are rarely seen in hospitals in the city (see Supp.
Info Text S1). The lack of obvious disease in hospitals and the
general population in Arequipa has led to speculation among local
physicians that the local strain of the etiologic agent, Trypanosoma
cruzi, has low chronic pathogenicity (personal observation), even
though it has caused fatal acute infections in infants [4] and animal
models[5,6].
The vast majority of the 8–10 million individuals infected with
T. cruzi [7] have the indeterminate form of Chagas disease. These
individuals exhibit no symptoms or signs of their infection, but
20% to 30% are expected to progress to cardiac or digestive forms
of chronic Chagas disease, which are difficult to treat and
potentially fatal [8–10]. Progression to clinically evident cardiac
disease is a slow process [8,10]. For vector-borne transmission,
decades may pass from the time of initial infection through contact
with the feces of an infected triatomine bug until the onset of
cardiac symptoms. Treatment with existing antitrypanosomal
drugs, benznidazole or nifurtimox, appears to slow or prevent
disease progression [9], but treatment is thought to be more
effective when administered early in the course of infection [11].
The long asymptomatic period of Chagas disease leads us to an
alternative hypothesis for the absence of clinical cases in Arequipa:
transmission in the city may be so recent that most infected
individuals have yet to progress to late stage disease. In order to
evaluate this hypothesis it is necessary to elucidate the timing of T.
cruzi infection in the population. The date of infection with T. cruzi
is rarely known for individuals with Chagas disease. No existing
assay of parasite or host factors yields reliable clues to the duration
of infection. The dynamic process of T. cruzi transmission, how-
ever, creates clear spatial and temporal patterns of infection in
insect vectors [12-14] and human hosts [15–20].
Traditionally, analyses of infectious diseases have aimed either
to describe risk factors for infection at a static moment in
transmission, using statistical methods to smooth heterogeneities in
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exposure between individuals created by the agent’s spread [21–
22], or to model the agent’s spread through time and space,
assuming a homogenous population [23]. Recent work has taken a
more unified approach, estimating parameters of spread and local
risk factors together [24–25]. Outside of a handful notable
exceptions, especially [26-27], most unified analysis of disease
spread and local risk factors address situations in which the time
and place of the introduction of the disease agent is known. Here
we develop a regression model, ‘epicenter regression,’ to infer the
temporal and spatial spread of a disease agent for the more
common situation in which the site or sites of introduction of a
disease agent is unknown.
Trypanosoma cruzi is a slow-moving parasite. When it is
transmitted in an epidemic phase, the period of time during
which each individual is exposed to infection varies greatly based
on how far away he or she lives from the site of introduction of the
parasite. The heterogeneity in exposure time that results from the
slow spread of the parasite may result in observable spatial
clustering of infections. Observed spatial clustering, however, may
also arise in endemic transmission if local risk factors for infection
are concentrated in certain areas. Epicenter regression explicitly
models the duration of an individual’s exposure as a function of
the distance of their household to an (unknown) site of intro-
duction of a disease, then, given the exposure time of each
individual’s household, estimates the effect of risk factors measured
in the house on the probability of infection for each individual. We
fit models to patterns of T. cruzi infection in insect vectors and
humans hosts in the peri-urban community of Guadalupe,
Arequipa, Peru [3,15]. We use Bayesian methods and Monte
Carlo Markov Chains (MCMCs), an approach which allows us to
make inference on parameters that reflect uncertainty about
unknown factors, such as the location of cases in a dynamic
infectious process [26–28].
We consider models with a single site of introduction of T. cruzi
as well as models with multiple sites and times of introductions
leading to multiple micro-epidemics. By ‘micro-epidemic’ we
mean a focus of transmission, seeded from the same introduction
of the parasite, that is discrete and discernable from the larger
pattern of transfomission in the community. We also compare
these models to an endemic model, in which each individual is
assumed to have been exposed to the parasite since birth. Under
the endemic model clustering of infection is explained mainly by
clustering of household risk factors. Using the estimates from these
models, we calculate the expected prevalence of infection among
the population for each calendar year up to disruption of
transmission through insecticide application in 2004. We discuss
how a more precise understanding of the history of transmission
might explain the absence of late-stage Chagas disease in
Arequipa, and potentially inform clinical management of individ-
uals with indeterminate Chagas disease.
Methods
Cross-sectional community survey
We conducted cross-sectional entomologic and serologic surveys
in one recent settlement (pueblo joven), Guadalupe, on the
southwestern margin of the city of Arequipa, Peru [14]. Vector-
borne transmission of Chagas disease in Guadalupe was disrupted
through application of deltamethrin insecticide in November of
2004. Concurrent to insecticide application, vector presence and
density were determined through one person-hour timed search by
trained professionals. Live and moribund fifth instar and adult
triatomines were examined for T. cruzi consecutively for each site
until 1 positive insect was found, 10 negative insects had been
examined, or all available insects had been examined, whichever
came first [14]. In August of 2005, all residents of the community
were invited to participate in a serological survey for Chagas
disease [15]. The positions of all households in Guadalupe were
determined with a handheld global positioning system (Garmin
Corporation, Olathe, KS, USA). Sera were screened using a
commercial enzyme-linked immunosorbent assay (ELISA) kit with
an epimastigote lysate antigen (Chagatek, Biomerieux, Buenos
Aires, Argentina) following the manufacturer’s instructions.
Positive ELISAs were confirmed by an immunofluorescent
antibody assay (IFA) following standard methods; a titer of 1:32
was considered positive. Statistical analysis of data from Guada-
lupe was approved by the Institutional Review Board of the
University of Pennsylvania.
Epicenter regression model
Epicenter regression makes inference on where and when a
disease agent was introduced into a community, as well as the effect
of household-level covariates on the risk of infection given exposure.
We begin with a simple model [29] in which an individual has a
constant risk of being infected once exposed. The probability that an
individual is infected is equal to 1 minus the probability of the
individual escaping infection: 1 - e -Risk given exposure . Duration of exposure. This
equation is known as the catalytic model, because it also describes
the probability of a change in state of molecules exposed to a
constant bombardment of a catalyst [30–31].
We expand this framework into a biologically plausible model
by allowing ‘risk given exposure’ and ‘duration of exposure’ to
vary among individuals depending on observed covariates, and
estimate the effect of the covariates from the observed data. We
estimate the risk of exposed individual, i, due to the covariates
measured in their household, j, using a traditional method to
estimate risk, a log-linear model: Riski = e
az
P
bX i . Here, Xi
represents a vector of covariates measured in each individual, and
the b parameter describes how those covariates increase or
decrease the log of the risk to each individual living in the exposed
household. We assume that the effect of each covariate is constant,
and varies neither year-to-year nor location-to-location. The
intercept term, a, denotes the baseline risk of exposed individuals
when all covariates are zero. We examined covariates previously
shown to be associated with T. cruzi infection in children in the
community. These included the presence of animals, almost
Author Summary
Chagas disease has become an urban problem in the city
of Arequipa, Peru, yet there are very few people exhibiting
severe symptoms of the disease. Severe symptoms often
do not appear until decades after infection. To determine
why so few people were exhibiting severe symptoms, we
used a new method, epicenter regression, to trace the
history of Chagas disease transmission in a community of
Arequipa, Peru. Our findings suggest that transmission in
Arequipa occurred through a series of small epidemics, the
oldest of which began only around 20 years ago. These
micro-epidemics infected nearly 5% of the community
before the insect that carries Chagas disease, Triatoma
infestans, was eliminated by insecticide application. Most
human infections in the study community arose over a
brief period of time immediately prior to the insecticide
application. According to our findings, the severe symp-
toms of Chagas disease are expected to be absent from
the community because of the short duration of infection
with the parasite, even among older individuals with
Chagas disease.
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exclusively dogs and cats, sleeping in the domestic area of the
household and the number of vectors in the domestic portion of
the household during timed entomologic search [15].
For each individual we estimated the period of time over which
he or she had been exposed to T. cruzi as the lesser of two more-
readily observable or estimable correlates of exposure: the
individual’s age, and the duration of exposure of their household.
We assume the time of exposure of a household is a function of
three unobserved parameters: T, the length of time since the
introduction of T. cruzi in the community; d, the distance of the
household from the household into which the parasite was first
introduced, and, r, the rate of spread of the parasite. In the present
analysis, we assume that a household becomes exposed at a time
proportional to its distance from the site of introduction of the
parasite. This assumption is a common simplification of
mathematical analysis of invasive organisms based on diffusion
equations, which concludes that, when individuals are assumed to
move according to random walks, the wave front of the population
will advance at a constant rate away from the site of introduction
[23]. The time after the introduction until the parasite reaches the
household, during which the residents of the household are not
exposed, is: djk/r, and the total duration of exposure is T- djk/r,
where djk is the distance of household j from the location of
introduction k. The probability of infection of individual i under
the model is: 1{e{(e
az
P
bX i ).(T{djk=r) for all individuals born before
their household was exposed to vectors carrying the parasite; and:
1{e{(e
az
P
bX i ).agei for all individuals born after their household was
exposed to vectors carrying the parasite.
A steep hilltop separated households in the study area. We
calculated the distance between the households going around this
hilltop. As in the related proportional hazards model [32], time of
exposure in epicenter regression must be limited to positive
values. In the above model if d/r is greater than T, then time of
exposure is set to zero, and the probability of infection is equal to
zero. We used data on the presence of T. cruzi in insects to further
refine our estimates of parameters T, d and r. For parameter
regimes in which the model predicted no exposure for households
in which we had observed T. cruzi in vectors, we set the likelihood
to zero.
Multiple introductions
We expanded our epicenter regression framework to consider
the possibility that T. cruzi was introduced into Guadalupe on
multiple occasions. Each introduction would occur in a different
household, k, at a different time, Tk. We calculate the duration
of exposure of individuals in household j due to introduction
into household k as: Tk – (djk/r). We assume that once
transmission is established in a household it remains established.
We also assume that the introduction of additional parasites into
a household in which transmission is already established does
not incrementally increase the risk of infection among those
living in the house. The duration of exposure of each individual
is therefore the maximum of their exposure to each introduc-
tion, or their age if their household was exposed prior to their
birth. The probability of infection of each individual is
otherwise as calculated above.
Endemic model
For comparison purposes, we fit an endemic model, in which we
assume that each individual’s time of exposure was equivalent to
their age. The infection probability of individual i living in
household j under the endemic model is: 1{e{(e
az
P
bX i ).agei .
Incorporation of prior knowledge
Bayesian analysis of epicenter regression begins with what is
known about the epidemic before testing people in the community,
the ‘‘priors’’ of the model [33]. A key assumption of the model is that
the parasite was introduced into a household and is spreading from
the site of introduction. Before observing the data we have no
information about into which household (or households) the parasite
was first introduced, and therefore set a uniform prior distribution
on the probability that each household was a site of introduction.
We set non-informative prior distrifbutions (Gaussian with a mean
of zero and a standard deviation of 103) on the effect of household-
level covariates (the bs). The community of Guadalupe was 40 years
old at the time of data collection. We therefore set a uniform prior,
bounded at 1 and 40 years, on the time since introduction of the
parasite, for each introduction, Tk.
Providing an explicit prior on the speed of spread of the
pathogen allows us to better tailor our analysis to the particulars of
T. cruzi transmission by T. infestans. We based our prior on the
speed of spread of the wavefront of T. cruzi on longitudinal data
from Villa la Joya, a community similar to Guadalupe in terms of
household density, history, and animal husbandry practices. In
Villa la Joya we surveyed 30% of households in January of 2008,
uncovering 6 sites of T. cruzi infection among triatomine bugs. We
conducted an exhaustive survey in conjunction with insecticide
application by the ministry of health, following the methodology
used in Guadalupe, in November and December of 2008. We
identified forty-four additional foci of T. cruzi in vectors, in well-
defined clusters around pre-existing sites of parasite presence,
during the exhaustive survey. Assuming that the parasite had
spread from the center of each cluster, it would have traveled
approximately 18 meters over the course of 10–12 month interval
between the preliminary and exhaustive surveys in order to reach
each of the 44 foci. In no case had the parasite spread farther than
58 meters from a pre-existing site. Based on these findings, we
assigned a normal distribution, with a mean of 20 meters and a
variance of 100 meters, to describe the prior probability on the
yearly speed of the spread of the parasite in Guadalupe. A spread
rate of 20 meters/year is akin to a single parasitic household
infecting on average between 6 and 7 additional households a year
when introduced into a susceptible community.
Model fitting, comparison, and prediction
We fit epicenter regression models using Bayesian methods and
Monte Carlo Markov Chains (MCMCs). We updated MCMCs
using the Metropolis and Metropolis-Hastings algorithms [33] (see
annotated code in technical appendix: Text S3, Dataset S1, Text
S4, Text S5). For the endemic model and models with 1 to 10
introductions, we ran 50 replicate MCMC chains, each of a length
of 1 million estimates. We discarded the first 100,000 and retained
every 10th estimate in the remainder of a chain to diminish
autocorrelation among the estimates. For each pair of models
compared, we estimated the Bayes factor by the average, over the
50 pairs of chains, of the ratio of harmonic means of the posterior
likelihood for the models [34]. We assured convergence of the
chains using Geweke’s test [35] as well as the Gelman-Rubin
statistic [36]. We considered models with 1 through 10 intro-
ductions of parasite into the population (see movies in supple-
mental materials: Text S2, Video S1, Video S2, Video S3, Video
S4). We estimated the prevalence for each calendar year under
alternative models by integrating the risk of infection per unit of
time over the time period that each individual was exposed.
Finally, we quantified the expected number of cases of late-stage
Chagas disease among individuals infected with T. cruzi at the time
of the study. The time between infection and development of late
Micro-Epidemics of Chagas Disease
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stage disease is note fully known, but generally estimated at
between 10 and 30 years [8]. We used three alternative models to
describe the probability of onset of late-stage disease as a function
of time: 1. A Poisson distribution centered at 20 years; 2. A
Gaussian distribution with a mean of 20 years and 95% of the
probability density between 10 and 30 years; and, 3. A uniform
distribution bounded at 10 and 30 years. For each of these we
integrated over the predicted temporal dynamics and calculated
the expected number of cases, and the probability of observing
exactly zero cases. We used a conservatively high estimate of the
proportion of individuals who will eventually develop late stage
disease, 30% [8].
Results
Models describing T. cruzi transmission as epidemic fit the data
collected in the community of Guadalupe much better than an
alternative, endemic model. The odds in favor of the epidemic
models compared to the endemic model increased more than 4
orders of magnitude after considering the observed data – i.e. the
Bayes’ factors comparing the epidemic models to the endemic model
exceeded 104 (Figure 1). A Bayes’ factor of greater than 10 is
considered ‘strong evidence’ in favor of one model over another [34].
Models describing transmission of T. cruzi as a series of focal micro-
epidemics were better supported than a model with a single epidemic
stemming from one site of introduction. In particular, a model with
four micro-epidemics had the greatest support from the observed
data; the odds in favor of this model compared to the single-epidemic
model increased 15-fold after considering the observed data (Figure 1).
Under the four-epicenter model, the parasite was first introduced
into Guadalupe about 20 years ago. When we tabulated the exposure
time and risk of infection of individuals in the population in the four-
epicenter model we found that around half of infections occurred in
the 5 years previous to disruption of transmission through insecticide
application, and 90% of infections occurred over a period of 12 years
(Figure 2). These estimates were consistent across models with 2 to 10
epicenters (Figure 2). In contrast, under the endemic model,
prevalence increased slowly over a much longer time frame.
Spatially, the first introduction in the four-epicenter model
occurred in the southwest of the community (Figure 3). A second
micro-epidemic was then seeded in the northwest of the community,
followed by a third in the southeast. Estimates on the position of the
fourth micro-epidemic varied; some centered on a household with
vectors carrying T. cruzi to the far east of Guadalupe, while others
were nearer to a household with a human case in the far north of the
community. Models with more than four introductions generally
further subdivided these micro-epidemics; such divisions decreased
the statistical support for these models.
Temporally the four-epicenter model captured the relationship
between age and prevalence observed in the data (Figure 4).
Estimates of the time of the first introduction of T. cruzi into the
community were remarkably similar across epidemic models
(19.98 years ago in the one-epicenter model, 20.31in the four-
epicenter model). The estimated effect of covariates on the risk of
Figure 1. Comparison of the fit of multi-epidemic models for
describing T. cruzi transmission in Guadalupe, Arequipa, Peru
to a single epidemic model. Shown are the mean and standard error
of the estimated Bayes’ factors for comparing each model to the 1
epicenter model. The dotted line denotes models with strong support
relative to the 1 epicenter model (Bayes’ factor .10).
doi:10.1371/journal.pcbi.1002146.g001
Figure 2. The expected percent of study participants infected
over each calendar year back to 1980. A. The expectation for
models with 2,4,6,8 and 10 epicenters; lines are shaded according to the
number of epicenters (2 epicenters-light grey, 10 epicenters = black). B.
A boxplot showing the median and credible intervals for the posterior
estimates from the best-fit four-epicenter regression model. Chagas
disease is a lifelong infection; infected individuals are assumed to
remain seropositive through their lifetimes.
doi:10.1371/journal.pcbi.1002146.g002
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infection given exposure were also similar, with a 1–2% increase of
risk per bug caught in the domestic area of the household and a
40–60% increase in risk among exposed individuals who allowed
animals to sleep inside the domestic area of the household at night
(Table 1). Posterior estimates on the rate of spread of T. cruzi,
however, varied greatly. In the best-fit four-epicenter model a
single exposed household would expose on average 4–5 additional
households per year in a susceptible community. By contrast, in
the one-epicenter model, the estimated rate of spread would
expose an unrealistically large number of households (on average
15 households/year in a susceptible community). The higher
estimated spread rate was counterbalanced by a lower estimated
risk of infection given exposure in the one-epicenter model
compared to the four-epicenter model.
When we combined our posterior model estimates of the timing of
infection with T. cruzi with three alternative models of the distribution
of waiting times between infection with the parasite and development
of late stage Chagas disease, we found very high probabilities of
observing less than one case of late stage disease in Guadalupe at the
time of our survey (Figure 5). Under the four-epicenter model the
probabilities of observing less than one case of late-stage disease were
0.696, 0.937, 0.967 under the Poisson, Gaussian and uniform models
respectively. Given the posterior estimates of the timing of T. cruzi
infection under the one-epicenter model, the probabilities of
observing fewer than one case were 0.797, 0.763, 0.779 under the
Poisson, Gaussian and uniform models.
Discussion
Transmission of Trypanosoma cruzi in peri-urban Arequipa occurs
in a series of spatially-focal micro-epidemics. The oldest of these
micro-epidemics in the community of Guadalupe began only
around 20 years ago. By the time vector-borne transmission of T.
cruzi was disrupted through insecticide application in 2004,
prevalence of human infection had reached 5% and was rapidly
climbing. The relatively high prevalence of infection seems to
conflict with the paucity of patients with Chagas cardiomyopathy
in local hospitals, leading some to conclude that the strain of
parasite in the region has low chronic pathogenicity. However, we
have shown that most infections in Guadalupe likely occurred over
a brief period of time prior to insecticide application. Our results
provide support for a different explanation for the lack of late-stage
Chagas disease in the city: the damage done by the vector and
parasite may be unobserved because most individuals have yet to
pass from the long asymptomatic period to symptomatic Chagas
disease.
Our findings do not disprove the hypothesis that the parasites
circulating in Arequipa are less pathogenic than other strains.
Previous studies suggest that T. cruzi strains in Arequipa are of
limited genetic diversity, possibly due to a founder effect [37–38]—a
finding, which if true, would be consistent with the results presented
here. We have typed fifteen isolates of T. cruzi from Arequipa
following methods described in [39]. The majority of strains, though
not all, are T. cruzi type I, including isolates from communities
neighboring Guadalupe [Vitaliano Cama, personal communication]. It is
absolutely possible that the particular strains of T. cruzi I that
predominate in Arequipa cause less chronic pathology. However,
we emphasize that, based on the results from our models, the lack of
late-stage Chagas cardiomyopathy in peri-urban Arequipa cannot
be taken as evidence of a weaker parasite, and that in the absence of
such evidence, preparations should be made for an increasing
burden of clinical disease in the region over the coming years.
Clinically, our findings may contribute to a re-evaluation of
treatment guidelines for indeterminate Chagas disease that is
currently underway [40–41]. Drug treatment is generally thought to
be more effective early in the course of T. cruzi infection [11].
Currently many countries, Peru included, do not routinely offer
treatment to patients over 15 years of age [1]. One justification for
this policy is based on the assumption that age is a good surrogate
for exposure to the parasite, and a reasonable surrogate of duration
of infection among cases. That is, in the absence of evidence to the
contrary, older individuals are assumed to have been carrying the
parasite for many years, and therefore to be less likely to benefit
from drug treatment. This assumption may be correct when
transmission follows an endemic pattern. However, when transmis-
sion occurs in an epidemic, or multiple micro-epidemics, the
assumption is incorrect. In peri-urban Arequipa and other epidemic
situations, age alone is not a valid surrogate for exposure. Temporal
and spatial information taken together give a better picture of how
long an individual has been exposed to T. cruzi.
Geographically, our finding that T. cruzi was first introduced in
the southwest of Guadalupe makes sense. Guadalupe is a peninsula,
surrounded on three sides by fields that provide no habitat to
triatomine vectors, while the southwest of the community borders a
large hillside of similar settlements with documented Chagas disease
transmission [3]. Once T. cruzi was introduced into the southwest of
Guadalupe it is clear that it did not spread house to house through a
simple diffusion process. Instead the parasite was transported to
other sites in the community, and there seeded new micro-
epidemics of transmission. We can only guess at the mechanism of
transport of the parasite. Animals, especially guinea pigs, are
Figure 3. Estimated geographic position of introductions of
Trypanosoma cruzi into the community of Guadalupe, Arequipa,
Peru. The probability that each household was the first (hexagons),
second (triangles), third (squares) or fourth (pentagons) site of
introduction under the four-epicenter model is shown. Larger shapes
correspond to higher probabilities. Households with cases of human
disease are shown as red circles, and those with vectors carrying T. cruzi
are shown in grey circles. The following steps were taken to protect
patient anonymity in making this map: The geographic position of
human cases has been slightly and randomly perturbed; the positions
of some uninfected households have been altered; and certain regions
of the map have been rotated a random angle around their centroid.
doi:10.1371/journal.pcbi.1002146.g003
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commonly gifted or traded both within and between communities;
infected guinea pigs could have sparked new micro-epidemics in
Guadalupe. Infected insects can also fly to establish new foci of
transmission; while the chance that any one insect establishes
transmission is very small [42], given a large number of dispersing
insects, establishment might occur occasionally. Individual-level
data on human migration histories might allow us to study whether
any infected individual was likely to have brought the parasite to
Guadalupe from elsewhere [43]. Our finding of a very recent history
of infections was robust to the precise number of micro-epidemics,
and it is unlikely to be affected if these micro-epidemics were
initiated through one mechanism rather than another.
Generally, our approach is applicable to any situation in which
the expected observation of an organism at sampling locations at
a certain time is a function of the (unknown) site or sites of
introduction of the organism into the system. The functional
relationship between the expectation at a sampling site to the site(s)
of introduction can be a simple function of distance, as we have
used here, or can include information about the habitat between
the sampling and introduction sites. The method can be
Figure 4. The observed and predicted relationship between age and prevalence of Trypanosoma cruzi infection in Guadalupe,
Arequipa, Peru. The histogram represents the observed data; a smoothed spline, weighted by the number of observations at each age, is fit to
these data (black curve). Model estimates of the relationship between age and prevalence were calculated by determining the probability of infection
for each individual derived from the posterior predictions of the epicenter regression model with four epicenters. The spline fit to the median
posterior predictions is surrounded by a region bounded by splines fit to predictions from the 2.5% and 97.5% quantiles of the posterior (light grey,
shaded).
doi:10.1371/journal.pcbi.1002146.g004
Table 1. Posterior estimates and credible intervals for endemic, single-epidemic and four micro-epidemic models of Trypanosoma
cruzi transmission in peri-urban Arequipa.
Parameter Endemic Model Single epidemic model Four micro-epidemic model
Median [2.5%, 97.5% cri1] Median [2.5%, 97.5% cri] Median [2.5%, 97.5% cri]
Rate of Spread of the Parasite (m/year) - 29.18 [17.52–44.69]2 17.35 [8.87–32.55]3
Baseline yearly risk of infection 0.0014 [0.0009–0.0020] 0.0032 [0.0018–0.0058] 0.0042 [0.0022–0.0086]
Relative risk per domiciliary insect captured 1.018 [1.004–1.028] 1.014 [1.000–1.024] 1.014[1.000–1.025]
Relative risk in households with animals
sleeping inside
1.34 [0.66–2.56] 1.53 [0.76–2.93] 1.42 [0.70–2.72]
Years since the first introduction of the parasite - 20.31 [12.71–33.25] 19.98 [10.92– 34.65]
1Credible intervals are the 2.5th and 97.5th quantiles of the posterior samples.
2Corresponds to an average of 15.01 [5.07, 34.26] households exposed by a single infected household in a fully-susceptible population.
3Corresponds to an average of 4.950 [1.01, 18.77] households exposed by a single infected household in a fully-susceptible population.
doi:10.1371/journal.pcbi.1002146.t001
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informative when some prior information, on the advance of the
disease agent or the likely sites of introduction, is available. The
method is not likely to be informative in the absence of both.
Our application of epicenter regression to T. cruzi transmission
simplifies what is, in reality, a complex transmission cycle, and it is
limited by the cross-sectional nature of the data. Our prior
information on the speed of spread of the parasite came from
empirical observations from another part of Arequipa; neverthe-
less the inherently stochastic nature of biological dispersal brings
into question our ability to extrapolate our observations in one
community to another [44]. Measurement of the Bayes’ factor is
also limited by errors of estimation [34]. Our primary goal was to
estimate the timing of T. cruzi infections, as opposed to estimating
the precise number of introductions of the parasite in the
community. Although the four micro-epidemic model was strongly
supported over the single-epicenter model, and substantially
supported over the two-epicenter model, there was little difference
in fit among models with 3-10 micro-epidemics. Other methods,
such as reversible jump MCMC [45], might be more efficient
when the number of introductions is of primary interest [28].
Our study focused on a single peri-urban community. Since the
completion of our study we have observed similar patterns of
micro-epidemics of T. cruzi transmission in entomologic data
across the southern half of the city of Arequipa (unpublished data).
In more rural areas outside the city, T. cruzi transmission was
disrupted in the mid 1990s [46]. There are additional anecdotal
reports of a lack of late-stage disease among individuals with
Chagas disease residing outside of the city. A lack of late-stage
disease among individuals infected many decades ago might
provide evidence of lower chronic pathogenicity. In contrast, a
finding of higher prevalence of late-stage disease among such
individuals would provide direct evidence against this hypothesis.
The traditional, endemic patterns of transmission of Trypanosoma
cruzi by Triatoma infestans have been largely disrupted across
southern South America through a concerted vector control
program known as the Southern Cone Initiative [1]. Currently the
initiative is challenged by vectors and parasites returning to areas
previously under insecticide control [13,40–42], and by new foci of
transmission in and around urban centers [14,15]. The micro-
epidemics of Chagas disease transmission we observed in Arequipa
may be typical following emergence or re-emergence of the vector
and parasite, rather than an anomalous pattern. Distinguishing
between epidemic and endemic transmission will improve
understanding of the dynamic relationship between prevalence
of T. cruzi infection and the burden of clinical Chagas disease.
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